Dr Ayesha Mahmood, MD | |
2100 Keystone Ave, Suite 402, Drexel Hill, PA 19026-1129 | |
(610) 394-4731 | |
(610) 394-4734 |
Full Name | Dr Ayesha Mahmood |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2100 Keystone Ave, Drexel Hill, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194754671 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD423490 (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ayesha Mahmood, MD 931 Clover Hill Rd, Wynnewood, PA 19096-1503 Ph: (610) 642-0671 | Dr Ayesha Mahmood, MD 2100 Keystone Ave, Suite 402, Drexel Hill, PA 19026-1129 Ph: (610) 394-4731 |
News Archive
Biovision, the annual forum devoted to future-oriented research in life sciences, is launching this years' registration campaign and its call for applications for innovative projects and companies. This year's event will take place in Lyon, France, on June 5 and 6, 2014.
First-String Research, Inc. (FSR), a spin-off biotechnology company from the Medical University of South Carolina (MUSC), has begun the human clinical trial process for its unique, wound-healing peptide gel.
Since its approval in 2011, the multiple sclerosis drug fingolimod (Gilenya) has already undergone three early benefit assessments, all of which were mainly based on the approval study TRANSFORMS. After a new modification of the therapeutic indication by the regulatory authorities, the Federal Joint Committee again commissioned the German Institute for Quality and Efficiency in Health Care to examine the added benefit of the drug in accordance with the Act on the Reform of the Market for Medicinal Products.
A new database of more than 4,000 Alzheimer's disease patients who have participated in 11 industry-sponsored clinical trials was released today by the Coalition Against Major Diseases. This is the first database of combined clinical trials to be openly shared by pharmaceutical companies and made available to qualified researchers around the world.
Shame is a common reaction when someone feels that they have fallen below social norms or their own standards. From being intoxicated in front of one's peers and superiors to failing an important test at school or being rejected at the school dance, shame can be an internal alarm that ensures that we know when we are at risk of finding ourselves outside the lines of societal acceptance and desirability.
› Verified 7 days ago